Epigallocatechin-3-gallate inhibits the invasion of salivary adenoid cystic carcinoma cells by reversing the hypermethylation status of the RECK gene

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 6031-6036

  Zhou, Xiao Qing ^a   Xu, Xiao Nan ^a   Li, Lei ^a   Ma, Jian Jun ^a   Zhen, En Ming ^a   Han, Cheng Bing ^b  

^a JINING NO 1 PEOPLE S HOSPITAL   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

Epigallocatechin 3 gallate; Hypermethylation; RECK; Salivary adenoid cystic carcinoma; Transwell assay

Indexed keywords

DNA; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; PROTEIN; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; UNCLASSIFIED DRUG; CATECHIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; RECK PROTEIN, HUMAN; TEA;

ADENOID CYSTIC CARCINOMA; ARTICLE; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; TUMOR INVASION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TEA; TUMOR CELL LINE;

CARCINOMA, ADENOID CYSTIC; CATECHIN; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GPI-LINKED PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; TEA;

EID: 84940473355     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4213     Document Type: Article

References (25)

1. Gondivkar SM, Gadbail AR, Chole R and Parikh RV. Adenoid cystic carcinoma: A rare clinical entity and literature review. Oral Oncol 47: 231-236, 2011.
2. Fordice J, Kershaw C, El-Naggar A and Goepfert H: Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125: 149-152, 1999.
3. Ehrlich M: DNA hypomethylation in cancer cells. Epigenomics 1: 239-259, 2009.
4. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054, 2003.
5. Latham, KE: X chromosome imprinting and inactivation in the early mammalian embryo. Trends Genet 12: 134-138, 1996.
6. Lyko F and Brown R: DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97: 1498-1506, 2005.
7. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates meth-ylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570, 2003.
8. Shao C, Tan M, Bishop JA, Liu J, Bai W, Gaykalova DA, Ogawa T, Vikani AR, Agrawal Y, Li RJ, et al: Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma. PLoS One 7: e485582, 2012.
9. Shao C, Sun W, Tan M, Glazer CA, Bhan S, Zhong X, Fakhry C, Sharma R, Westra WH, Hoque MO, et al: Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res 17: 4320-4330, 2011.
10. Fan X, Chen B, Xu J, Zhang H, Deng F and Xiang X: Methylation status of the PTEN gene in adenoid cystic carcinoma cells. Mol Med Rep 3: 775-779, 2010.
11. Daa T, Kashima K, Kondo Y, Yada N, Suzuki M and Yokoyama S: Aberrant methylation in promoter regions of cyclin-dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary gland. APMIS 116: 21-26, 2008.
12. Williams MD, Chakravarti N, Kies MS, Maruya S, Myers JN, Haviland JC, Weber RS, Lotan R and El-Naggar AK: Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res 12: 7353-7358, 2006.
13. Clark JC, Thomas DM, Choong PF and Dass CR: RECK-a newly discovered inhibitor of metastasis with prognostic signifcance in multiple forms of cancer. Cancer Metastasis Rev 26: 675-683, 2007.
14. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, et al: RECK expression in pancreatic cancer: Its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9: 1779-1784, 2003.
15. Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S and Moriuchi T: Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer 58: 376-383, 2007.
16. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID and Sogayar MC: Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9: 20, 2009.
17. Zhang C, Ling Y, Xu Y, Gao L, Li R, Zhu J, Fan L and Wei L: The silencing of RECK gene is associated with promoter hyper-methylation and poor survival in hepatocellular carcinoma. Int J Biol Sci 8: 451-458, 2012.
18. Zhou X, Huang S, Jiang L, Zhang S, Li W, Chen Z and Zhang D: Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Oncol Lett 7: 1549-1555, 2014.
19. Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H and Shibata T: Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99: 647-654, 2008.
20. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, et al: The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789-800, 2001.
21. Echizenya M, Kondo S, Takahashi R, Oh J, Kawashima S, Kitayama H, Takahashi C and Noda M: The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors. Oncogene 24: 5850-5857, 2005.
22. Cho CY, Wang JH, Chang HC, Chang CK and Hung WC: Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol 213: 65-69, 2007.
23. Chang HC, Cho CY and Hung WC: Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci 98: 169-173, 2007.
24. Hellebrekers DM, Griffioen AW and van Engeland M: Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta 1775: 76-91, 2007.
25. Shaw RJ, Hall GL, Lowe D, Bowers NL, Liloglou T, Field JK, Woolgar JA and Risk JM: CpG island methylation phenotype (CIMP) in oral cancer: Associated with a marked infammatory response and less aggressive tumour biology. Oral Oncol 43: 878-886, 2007.